Tyra Biosciences, Inc. TYRA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Tyra Biosciences Inc. is a biotechnology company focused on developing precision therapies to address drug resistance in cancer treatments. Founded with the mission to advance cancer therapy through targeted innovation, Tyra Biosciences specializes in creating small-molecule inhibitors that can overcome the limitations…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees87
TickerTYRA
Statistics
Market Cap$1.71B
Revenue (TTM)$0
Net Income-$119.9M
Net Margin—
EPS$-2.01
P/E-12.72
P/S—
P/B5.27
EV/EBITDA-7.96
ROE-36.9%
Dividend Yield—
Price$28.69
Data: Twelve Data · Revenue = mcap / P/S